Thalassemia natural history, complications and prognosis

Revision as of 20:16, 9 November 2017 by Shyam Patel (talk | contribs)
Jump to navigation Jump to search

Thalassemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thalassemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thalassemia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thalassemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thalassemia natural history, complications and prognosis

CDC on Thalassemia natural history, complications and prognosis

Thalassemia natural history, complications and prognosis in the news

Blogs on Thalassemia natural history, complications and prognosis

Directions to Hospitals Treating Thalassemia

Risk calculators and risk factors for Thalassemia natural history, complications and prognosis

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

Natural History

Complications

The complications of thalassemia are largely related to iron overload from repeated transfusions. Iron deposition can occur in various organs.

  • Cardiac failure: Iron deposition in the heart can cause an infiltrative cardiomyopathy. Symptoms of iron overload in the heart include shortness of breath, chest pain, decreased exercise tolerate, edema, and occasionally abdominal distension. The diagnosis of cardiac iron overload typically involves obtaining an echocardiogram (to assess for diastolic and systolic dysfunction). Echocardiogram can show a sparkled appearance of the involved chambers (from iron deposits) and sometimes a decreased ejection fraction). EKG typically shows low-voltage QRS complexes, due to the impaired electrical conduction through a disease heart containing significant iron. Laboratory workup that can assist with diagnosis includes measurement of troponin and nt-proBNP.
  • Thyroiditis: Infiltrative thyroiditis can occur with iron overload from repeated transfusions from thalassemia. Iron deposition in the thyroid can be assessed via thyroid ultrasound and measurement of thyroid-stimulating hormone (TSH) and free thyroxine (t4) levels.

Iron deposi Untreated thalassemia major eventually leads to death usually by heart failure. Therefore, birth screening is very important. β-thalassemia cardiomyopathy takes on two phenotypes:

  • Dilated phenotype: Left ventricular dilatation and impaired contractility are present.
  • Restrictive phenotype: Restrictive left ventricular filling is present along with pulmonary hypertension, and right heart failure.

The pathophysiology of β-Thalassemia cardiomyopathy is multifactorial, with myocardial iron overload and immunoinflammatory processes being the predominant mechanisms.

All Thalassemia patients are susceptible to health complications that involve the spleen (which is often enlarged and frequently removed) and gall stones. These complications are mostly prevalent to thalassemia Major and Intermedia patients.

Prognosis

References

Template:WH Template:WS